Choice ✔ investment

Choose stocks

Create and
share portfolios

Study reporting
public companies

AGE - Company Financial Ratios

AgeX Therapeutics, Inc.

AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company`s lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-related metabolic disorders, such as Type II adult-onset diabetes; and AGEX-VASC1, a cell-based therapy to restore vascular support in aged ischemic tissues, such as the ischemic heart. Its lead drug-based therapeutic candidate in discovery is AGEX-iTR1547, a drug-based formulation to restore regenerative potential in a range of aged tissues afflicted with degenerative diseases. In addition, the company markets human embryonic stem cells; and GeneCards Database Suite, including genomic interpretation algorithms and analysis tools for use by researchers at pharmaceutical and biotechnology companies, and other institutions. AgeX Therapeutics, Inc. ha

United States    http://www.agexinc.com
Healthcare Biotechnology AMEX | NYSE American

0 1.91

period
2021 1.85 69.71 - 2.27 0.00 0.00 0.00 0.000 0.00 0.00 21.53 - 246.37 0.00
2019 1.41 53.00 - 4.32 0.21 23.69 0.000 0.00 2.36 30.41 - 163.32 - 547.97
2018 3.93 137.00 - 18.29 0.85 18.43 0.000 0.00 0.43 98.29 - 70.30 - 100.74
2016 3.70 133.00 - 8.56 0.41 - 5.66 0.000 0.00 - 1.09 79.57 - 480.67 66.15